An electron transport chain inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Buparvaquone

Item No. 21704

Technical Information
Formal Name
2-[[4-(1,1-dimethylethyl)cyclohexyl]methyl]-3-hydroxy-1,4-naphthalenedione
CAS Number
88426-33-9
Synonyms
  • BW 720C
Molecular Formula
C21H26O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 1 mg/mlDMF:PBS (pH 7.2) (1:5): 0.16 mg/mlDMSO: 1 mg/mlEthanol: Slightly Soluble
λmax
252, 282, 332 nm
SMILES
OC1=C(CC2CCC(C(C)(C)C)CC2)C(C3=CC=CC=C3C1=O)=O
InChi Code
InChI=1S/C21H26O3/c1-21(2,3)14-10-8-13(9-11-14)12-17-18(22)15-6-4-5-7-16(15)19(23)20(17)24/h4-7,13-14,24H,8-12H2,1-3H3
InChi Key
KLLIVCPQDTYMLC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Buparvaquone is a hydroxynaphthoquinone that inhibits electron transport by blocking cytochrome bc1 in parasites that cause leishmaniasis.1 Formulations containing buparvaquone are used to treat theileriosis, an infection by the parasites T. annulata and T. parva (in vitro EC50s of 1.5 x 10-8 M and 6.1 x 10-10 M, respectively).2,3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ortiz, D., Forquer, I., Boitz, J., et alTargeting the cytochrome bc1 complex of Leishmania parasites for discovery of novel drugs. Antimicrob. Agents and Chemother. 60(8), 4972-4982 (2016).

    2. Abdou, T.A., Abou-El-naga, T.R., and Mahmoud, M.A. Clinicopathological studies on Theileria annulata infection in Siwa oasis in Egypt. 56th Annual Meeting of the European Association for Animal Production 70 (2005).

    3. Hudson, A.T., Randall, A.W., Fry, M., et alNovel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Parasitology 90(Pt 1), 45-55 (1985).